OCTOBER 23, 2026
Subscribe
Global Press Media · World Report
Business

Former OpenAI Researcher Raises $215 Million to Automate Wet‑Lab Work with Robots

Former OpenAI Researcher Raises $215 Million to Automate Wet‑Lab Work with Robots

This week, biotech newcomer Warp Science disclosed its launch and revealed a $215 million funding round spearheaded by the venture capital firm Lightspeed. The proceeds are earmarked for building robotic platforms capable of handling everyday lab tasks—such as pipetting and sample manipulation—to convert conventional wet‑lab operations into largely automated workflows.

Its founder formerly led the scientific division at OpenAI, directing projects that fused artificial intelligence with hands‑on experimentation. Upon departing the AI company, he focused on the persistent bottlenecks in biology, pointing out that numerous experiments stay labor‑heavy even as computational technologies progress.

The startup intends to combine modular robotic arms, vision‑driven quality‑control systems, and software that converts experimental protocols into machine‑readable code. By taking over repetitive duties, the solution aims to liberate researchers for higher‑level analysis and speed up discovery, especially in drug discovery and synthetic biology where speed and reproducibility are vital.

Receiving $215 million situates Warp Science within an expanding group of firms aiming to upgrade lab infrastructure. Venture capital has been pouring into automation lately, with companies like Benchling, LabTwin and peers securing substantial funding in recent times. Analysts interpret the hefty round as a strong endorsement of the market potential for fully robotic wet‑lab workflows, a field that has traditionally trailed behind data‑focused AI solutions.

Although the system remains at the prototype phase, Warp Science plans to roll out its inaugural commercial product in the coming 12 to 18 months, aiming at major research centers and pharma R&D laboratories. The firm must address regulatory issues tied to lab equipment and prove dependable performance before wider uptake. Should it succeed, the venture could transform experimental biology, ushering in a period where robots manage routine tasks while scientists concentrate on hypothesis formulation and analysis.

Source: techcrunch
Editorial Desk — Editorial desk.

Comments (0)

Be the first to comment.

Join the discussion

Protected by reCAPTCHA v3

Related